Your browser doesn't support javascript.
loading
Activity of singly and doubly modified derivatives of C20-epi-salinomycin against Staphylococcus strains.
Czerwonka, Dominika; Podsiad, Malgorzata; Stefanska, Joanna; Antoszczak, Michal; Huczynski, Adam.
Affiliation
  • Czerwonka D; Department of Medical Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznanskiego 8, 61-614, Poznan, Poland.
  • Podsiad M; Department of Biochemistry, Medical University of Warsaw, 02-097, Warsaw, Poland.
  • Stefanska J; Laboratory of Pharmaceutical Microbiology, Centre for Preclinical Research, Medical University of Warsaw, 02-097, Warsaw, Poland.
  • Antoszczak M; Department of Medical Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznanskiego 8, 61-614, Poznan, Poland. michant@amu.edu.pl.
  • Huczynski A; Department of Medical Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznanskiego 8, 61-614, Poznan, Poland.
J Antibiot (Tokyo) ; 75(8): 445-453, 2022 08.
Article in En | MEDLINE | ID: mdl-35760901
ABSTRACT
Natural polyether ionophore salinomycin (Sal) has been widely used in veterinary medicine as an antibiotic effective in the treatment of coccidian protozoa and Gram-positive bacteria. Moreover, chemical modification of the Sal structure has been found to be a promising strategy to generate semisynthetic analogs with biological activity profiles improved relative to those of the native compound. In this context, we synthesized and thoroughly evaluated the antibacterial potential of a library of C1/C20 singly and doubly modified derivatives of C20-epi-salinomycin, that is, analogs of Sal with inversed stereochemistry at the C20 position. Among the synthesized analog structures, the most promising antibacterial active agents were those obtained via regioselective O-acylation of C20-epi-hydroxyl, particularly esters 7, 9, and 11. Such C20 singly modified compounds showed excellent inhibitory activity against planktonic staphylococci, both standard and clinical strains, and revealed potential in preventing the formation of bacterial biofilms. In combination with their non-genotoxic properties, these Sal derivatives represent attractive candidates for further antimicrobial drug development.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrans / Staphylococcus Language: En Journal: J Antibiot (Tokyo) Year: 2022 Document type: Article Affiliation country: Poland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrans / Staphylococcus Language: En Journal: J Antibiot (Tokyo) Year: 2022 Document type: Article Affiliation country: Poland